Found 219 articles for: "Open Access"
FULL SUPPLEMENT: Obesity: The Impact on Biologic Selection
January 2025 | Volume 24 | Issue 1 | Supplement | 491710s1 | Copyright © January 2025
Obesity is a multifactorial disease with a rapidly increasing global prevalence. Its etiology is driven by a chronic imbalance between energy intake and energy expenditure. Excess energy is stored in ...
Read MoreINDIVIDUAL ARTICLE: Psoriasis Is a Systemic Disease
January 2025 | Volume 24 | Issue 1 | Supplement Individual Articles | 491711s2 | Copyright © January 2025
INDIVIDUAL ARTICLE: Psoriasis and Obesity: Optimizing Pharmacologic Treatment and Lifestyle Interventions
January 2025 | Volume 24 | Issue 1 | Supplement Individual Articles | 491722s4 | Copyright © January 2025
Obesity is a metabolic disease that is marked by excessive fat accumulation and is objectively defined as a body mass index (BMI) ≥30 kg/m2. Obesity is associated with several other...
Read MoreFULL SUPPLEMENT: Real-World Cases Using Topical Clascoterone Cream in Acne
January 2025 | Volume 24 | Issue 1 | Supplement | 733610s1 | Copyright © January 2025
Acne vulgaris affects approximately 80% of young adults and adolescents in the world. Acne presents as comedones, pustules, papules, and nodules on the face, chest, shoulders, or back. It can lead to ...
Read MoreINDIVIDUAL ARTICLE: Real-World Cases of Clascoterone Topical Treatment for Acne and Related Disorders
January 2025 | Volume 24 | Issue 1 | Supplement Individual Articles | 73361s3 | Copyright © January 2025
Acne vulgaris affects approximately 80% of young adults and adolescents in the world. Acne presents as comedones, pustules, papules, and nodules on the face, chest, shoulders, or back. It can lea...
Read MoreVessel-Targeting Therapies for the Management of Rosacea: A Review of Current Evidence
January 2025 | Volume 24 | Issue 1 | Editorial | 105 | Copyright © January 2025
Cutaneous Oncodermatology Preventing Manging Cutaneous Targeted Therapy
December 2024 | Volume 23 | Issue 12 | Supplement | 436613s16a | Copyright © December 2024
In 2023, an estimated 1,958,310 Americans were diagnosed with cancer.1 Although overall incidence continues to rise, ongoing advancements in anticancer therapy have improved survival. Some ...
Read MoreINDIVIDUAL ARTICLE: USCOM IV Algorithm for the Prevention and Management of Targeted Therapy-Related Cutaneous Adverse Events
December 2024 | Volume 23 | Issue 12 | Supplement Individual Articles | 436613s3 | Copyright © December 2024
Introduction: Targeted therapy has improved clinical outcomes for various types of cancer. However, their use is associated with dermatologic adverse events that impact quality o...
Read MoreIL-36 Trials in Dermatology: Cross-Sectional Analysis of ClinicalTrials.gov-Registered Trials
December 2024 | Volume 23 | Issue 12 | Editorials | e195 | Copyright © December 2024
Light and Laser-Imaging Detection and Ranging (LiDAR) in Dermatology: A New Dimension for Digital Healthcare
December 2024 | Volume 23 | Issue 12 | Editorials | e197 | Copyright © December 2024
Social Media and the Dermatologist
December 2024 | Volume 23 | Issue 12 | Features | 1125 | Copyright © December 2024
Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient Journey
November 2024 | Volume 23 | Issue 11 | Case Reports | 1017 | Copyright © November 2024
Introduction: Topical clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% (CAB) gel is the only fixed-dose, triple-combination formulation approved for acne treatmen...
Read MoreFULL SUPPLEMENT: Topical Acne Treatment: What's Behind the Scenes in 2024
November 2024 | Volume 23 | Issue 11 | Supplement | 46941s1 | Copyright © November 2024
Optimal topical acne treatments should ideally target multiple pathways involved in acne development.2 Traditional treatments, though often effective, may come with limitations such as skin irri...
Read MoreINDIVIDUAL ARTICLE: VEHICLES ALWAYS MATTER
November 2024 | Volume 23 | Issue 11 | Supplement Individual Articles | 46941s3 | Copyright © November 2024
Over the past several years, the field of acne treatments, which had been relatively unchanged, has welcomed a variety of innovations. From new molecules and mechanisms of action to previously implaus...
Read MoreINDIVIDUAL ARTICLE: All for One and One for All: The Three Musketeers of Topical Acne Treatment and the Current Landscape
November 2024 | Volume 23 | Issue 11 | Supplement Individual Articles | 46942s4 | Copyright © November 2024
What is the ideal topical acne therapeutic? Topical therapeutics for acne vulgaris have advanced considerably over the last decade. Novel vehicular technologies have increased transdermal penetra...
Read MoreFULL SUPPLEMENT: Real-World Clinical Experience Combining A Neuro-Peptide Serum And Botulinum Toxin Type-A Injections
November 2024 | Volume 23 | Issue 11 | Supplement | 43661s1 | Copyright © November 2024
By 2050, the World Health Organization (WHO) estimates that the world's population of people aged 65 years and older will have more than doubled from 761 million in 2021. As the population and their s...
Read MoreINDIVIDUAL ARTICLE: Real-World Clinical Experience With a Neuro-Peptide Serum in Combination With Botulinum Toxin Type-A Injections
November 2024 | Volume 23 | Issue 11 | Supplement Individual Articles | 43661s3 | Copyright © November 2024
We evaluated real-life experiences of a topical neuro-peptide serum containing 2% acetyl hexapeptide-8, 2% dipeptide diaminobutyroyl, 5% polyhydroxy acids (PHA), 5% niacinamide, and 1% laminaria ...
Read MoreNew Formulations of Acyclothymidine Dinucleosides Reduce Damaging Effects of Ultraviolet Radiation in an Ex Vivo Skin Model
November 2024 | Volume 23 | Issue 11 | Original Article | 953 | Copyright © November 2024
The greatest risk factor for skin cancer is exposure to ultraviolet (UV) rays of the sun. Among the three types of solar radiation (UVA, UVB, UVC), UVB rays are most commonly associated with skin...
Read MoreAttitudes on, Practices, and Recommendations for Visible Light Protection Amongst Dermatology Practitioners
November 2024 | Volume 23 | Issue 11 | Original Article | 965 | Copyright © November 2024
Background: Iron oxides, antioxidants, and pigmentary titanium dioxide are sunscreen additive ingredients that enhance visible light protection, reduce associated hyperpigme...
Read MoreCost Analysis of Sunscreens Targeted Towards Skin of Color
November 2024 | Volume 23 | Issue 11 | Features | e181 | Copyright © November 2024
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
